Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

BOLD

Boundless Bio Inc

Feb 09 • 04:00PM ET

1.14

-0.01 -1.29 %

Healthcare • Biotechnology • USA • NASD

Peers: BLUE NTLA CRSP EDIT SGMO BNGO CERS MESO FATE CLLS

| Held by: VTI VXF IWC

Index	-	P/E	-	EPS (ttm)	-2.77	Insider Own	28.92%	Shs Outstand	22.39M	Perf Week	1.33%
Market Cap	25.63M	Forward P/E	-	EPS next Y	-2.10	Insider Trans	0.00%	Shs Float	15.91M	Perf Month	-12.60%
Enterprise Value	-42.18M	PEG	-	EPS next Q	-0.52	Inst Own	40.68%	Short Float	0.33%	Perf Quarter	-9.13%
Income	-61.76M	P/S	-	EPS this Y	35.84%	Inst Trans	1.92%	Short Ratio	0.31	Perf Half Y	6.02%
Sales	0.00M	P/B	0.23	EPS next Y	14.84%	ROA	-35.93%	Short Interest	0.05M	Perf YTD	-4.58%
Book/sh	4.92	P/C	0.22	EPS next 5Y	35.63%	ROE	-44.88%	52W High	2.48 -53.83%	Perf Year	-51.48%
Cash/sh	5.25	P/FCF	-	EPS past 3/5Y	-50.29% -	ROIC	-39.37%	52W Low	0.96 19.12%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.26% 6.97%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-0.50%	Oper. Margin	-	ATR (14)	0.08	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.14	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	44.68	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.14	EPS Q/Q	16.42%	SMA20	-4.16%	Beta	-0.18	Target Price	3.00
Payout	-	Debt/Eq	0.45	Sales Q/Q	-	SMA50	-3.77%	Rel Volume	0.62	Prev Close	1.16
Employees	64	LT Debt/Eq	0.42	Earnings	Nov 05 BMO	SMA200	-6.95%	Avg Volume	169.02K	Price	1.14
IPO	Mar 28, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	-6.44% -	Trades		Volume	105,284	Change	-1.29%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-02-25	Initiated	H.C. Wainwright	Buy	$5
May-28-25	Downgrade	Leerink Partners	Outperform → Market Perform	$3
Dec-13-24	Downgrade	Guggenheim	Buy → Neutral
Apr-22-24	Initiated	Piper Sandler	Overweight	$20
Apr-22-24	Initiated	Leerink Partners	Outperform	$25
Apr-22-24	Initiated	Guggenheim	Buy	$24

Feb-05-26 07:00AM	Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 (GlobeNewswire)
Jan-20-26 07:00AM	Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway (GlobeNewswire)
Nov-24-25 07:00AM	Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-05-25 07:00AM	Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights (GlobeNewswire)
Oct-13-25 04:05PM	Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
07:00AM	Loading…
Aug-05-25 07:00AM	Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights (GlobeNewswire)
Jun-05-25 04:58PM	Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire)
May-23-25 04:01PM	Boundless Bio Announces Portfolio Prioritization and Runway Extension (GlobeNewswire) -15.58%
May-14-25 12:00PM	Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's What You Should Know (Zacks)
May-09-25 07:00AM	Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights (GlobeNewswire)
May-01-25 08:23AM	New Strong Sell Stocks for May 1st (Zacks) -8.52%
Apr-03-25 07:00AM	Boundless Bio to Participate in the Needham Virtual Healthcare Conference (GlobeNewswire) -7.38%
Mar-27-25 07:00AM	Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights (GlobeNewswire)
Feb-26-25 07:00AM	Boundless Bio to Participate in the Leerink Global Healthcare Conference (GlobeNewswire)
Feb-03-25 10:00AM	Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer (GlobeNewswire)
04:01PM	Loading…
Dec-12-24 04:01PM	Boundless Bio Announces Pipeline and Leadership Updates (GlobeNewswire) -12.72% -16.61%
Nov-25-24 07:00AM	Boundless Bio to Participate in the Piper Sandler Healthcare Conference (GlobeNewswire) +8.94%
Nov-07-24 04:01PM	Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights (GlobeNewswire) +5.42%
Nov-05-24 07:00AM	Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference (GlobeNewswire)
Oct-14-24 08:00AM	Boundless Bio Announces Departure of Chief Financial Officer (GlobeNewswire)
Sep-11-24 07:00AM	Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference (GlobeNewswire)
Aug-13-24 04:28AM	Sluggish enrollment leads Boundless Bio to make 'modest' layoffs 5 months after $100M IPO (FierceBiotech.com)
03:32AM	Boundless Bio, Inc. (BOLD): Why Should You Buy This New Penny Stock Now? (Insider Monkey)
Aug-12-24 10:53PM	BOLD Stock Earnings: Boundless Bio Beats EPS for Q2 2024 (InvestorPlace) -6.19%
04:01PM	Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jun-05-24 07:00AM	Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
May-13-24 02:53PM	BOLD Stock Earnings: Boundless Bio Reported Results for Q1 2024 (InvestorPlace) +10.83%
07:00AM	Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights (Business Wire)
May-06-24 08:00AM	Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024 (Business Wire)
May-01-24 10:05AM	Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 (PR Newswire)
11:37AM	Loading…
Apr-14-24 11:37AM	Insiders are Amassing These 10 Stocks in April (Insider Monkey)
Apr-11-24 08:00AM	Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications (Business Wire)
Apr-08-24 08:00AM	Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024 (Business Wire) -5.75%
Mar-27-24 06:55PM	Boundless Bio Announces Pricing of Initial Public Offering (Business Wire)

Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA.

Open in Screener

SANA

Sana Biotechnology Inc

Feb 09 • 04:00PM ET

4.00

+0.07 1.78 %

Healthcare • Biotechnology • USA • NASD

SANA Sana Biotechnology Inc daily Stock Chart

Peers: VERV PRME NTLA EDIT TSHA CRBU CABA BEAM MGTX PGEN

| Held by: VTI XBI IWM VXF IWN IBB VTWO SCHA VHT PRFZ

Index	RUT	P/E	-	EPS (ttm)	-0.97	Insider Own	37.73%	Shs Outstand	262.26M	Perf Week	-12.85%
Market Cap	1.07B	Forward P/E	-	EPS next Y	-0.56	Insider Trans	0.00%	Shs Float	165.85M	Perf Month	-11.50%
Enterprise Value	990.46M	PEG	-	EPS next Q	-0.14	Inst Own	47.70%	Short Float	22.38%	Perf Quarter	-1.23%
Income	-234.41M	P/S	-	EPS this Y	25.60%	Inst Trans	4.94%	Short Ratio	9.76	Perf Half Y	33.33%
Sales	0.00M	P/B	5.37	EPS next Y	35.22%	ROA	-47.13%	Short Interest	37.11M	Perf YTD	-1.72%
Book/sh	0.74	P/C	6.78	EPS next 5Y	19.30%	ROE	-96.11%	52W High	6.55 -38.93%	Perf Year	22.70%
Cash/sh	0.59	P/FCF	-	EPS past 3/5Y	18.55% -10.60%	ROIC	-89.07%	52W Low	1.26 217.46%	Perf 3Y	-18.70%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.77% 7.55%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	31.16%	Oper. Margin	-	ATR (14)	0.35	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.55	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	41.97	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	4.55	EPS Q/Q	36.45%	SMA20	-11.61%	Beta	1.98	Target Price	8.17
Payout	-	Debt/Eq	0.42	Sales Q/Q	-	SMA50	-11.54%	Rel Volume	0.54	Prev Close	3.93
Employees	194	LT Debt/Eq	0.35	Earnings	Nov 06 AMC	SMA200	8.50%	Avg Volume	3.80M	Price	4.00
IPO	Feb 04, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	15.25% -	Trades		Volume	2,053,623	Change	1.78%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-24-25	Initiated	Wedbush	Outperform	$5
Jul-03-25	Resumed	Morgan Stanley	Overweight	$12
Mar-18-25	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform	$5
Mar-14-25	Initiated	Jefferies	Buy	$7
Jan-08-25	Upgrade	TD Cowen	Hold → Buy
Nov-05-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-26-24	Initiated	Rodman & Renshaw	Buy	$16
Jan-16-24	Upgrade	H.C. Wainwright	Neutral → Buy	$12
Sep-25-23	Initiated	JMP Securities	Mkt Outperform	$9
Sep-05-23	Initiated	Citigroup	Buy	$8
Aug-14-23	Initiated	TD Cowen	Market Perform
May-02-23	Initiated	H.C. Wainwright	Neutral
Mar-01-21	Initiated	Morgan Stanley	Overweight	$40
Mar-01-21	Initiated	JP Morgan	Neutral	$35
Mar-01-21	Initiated	Goldman	Neutral	$40
Mar-01-21	Initiated	BofA Securities	Buy	$45

Show Previous Ratings

Jan-30-26 12:00PM	Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know (Zacks)
Jan-23-26 09:55AM	Wall Street Analysts Think Sana (SANA) Could Surge 74.2%: Read This Before Placing a Bet (Zacks)
Jan-07-26 04:26PM	Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +8.49%
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +7.39%
Dec-28-25 10:05AM	Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication (Insider Monkey)
09:00AM	Loading…
Dec-08-25 09:00AM	Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform (GlobeNewswire) -9.75%
Nov-28-25 10:11AM	Sana (SANA) Surges 14.5% Ahead of Business Announcements (Insider Monkey) +6.97%
Nov-24-25 04:05PM	Sana Biotechnology to Present at December 2025 Investor Conferences (GlobeNewswire) +7.60%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks)
06:17AM	Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength (Insider Monkey)
Nov-12-25 12:00PM	All You Need to Know About Sana (SANA) Rating Upgrade to Buy (Zacks)
Nov-06-25 04:26PM	Sana: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
Nov-04-25 04:05PM	Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit (GlobeNewswire) -9.19%
Oct-15-25 12:07PM	Progressive stock sinks on Q3 miss, gold hits yet another record (Yahoo Finance Video) +33.03%
10:45AM	Loading…
10:45AM	Sana Biotechnology stock higher after Eric Jackson touts 100-bagger potential (Investing.com)
Sep-20-25 02:43AM	Sana Biotechnology Inc. (SANA) Bolsters Management Team (Insider Monkey)
Sep-17-25 02:18PM	Can Sana Biotechnology's (SANA) Pipeline Momentum Translate into More Share Price Upside? (Insider Monkey)
Sep-15-25 07:30AM	3 Stocks to Buy Under $10 That Could Triple From Here (Barchart)
Sep-08-25 12:30AM	JMP Securities Keeps Market Outperform Rating on Sana Biotechnology (SANA) (Insider Monkey)
Aug-26-25 04:05PM	Sana Biotechnology to Present at September 2025 Investor Conferences (GlobeNewswire)
Aug-25-25 11:56PM	Citizens JMP Reiterates a Buy Rating on Sana Biotechnology (SANA) With a $5 PT (Insider Monkey) -6.42%
Aug-20-25 04:05PM	Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Aug-12-25 11:43AM	Sana Biotech Bails on Factory in Old AT&T Call Center (IEN) +6.51%
Aug-11-25 06:11PM	Sana: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
Aug-07-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) -30.12%
Aug-06-25 11:24PM	Sana Biotechnology Announces Pricing of Public Offering (GlobeNewswire)
04:38PM	Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
07:00AM	Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates (GlobeNewswire)
11:35AM	Loading…
Aug-04-25 11:35AM	Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes (GlobeNewswire) +8.18%
Aug-01-25 06:47AM	Sana Biotechnology (SANA) Rated 'Market Perform' on Diabetes Program Prospects (Insider Monkey)
Jul-31-25 11:40PM	Citi Remains Bullish on Sana Biotechnology (SANA) (Insider Monkey) -6.88%
Jul-23-25 11:25AM	Citi Maintained a Buy Rating on Sana Biotechnology (SANA) (Insider Monkey) +5.54%
Jul-11-25 07:11PM	Sana Biotechnology, Inc. (SANA) Secures an Overweight Rating from Morgan Stanley (Insider Monkey)
Jul-03-25 09:09AM	Sana Reports Promising Diabetes Cell Therapy Data at ADA Meeting (Insider Monkey) +9.25%
Jun-24-25 03:51PM	BofA Remains Bullish on Sana Biotechnology (SANA) (Insider Monkey) +14.23%
Jun-23-25 10:05AM	Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression (GlobeNewswire)
Jun-09-25 04:05PM	Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions (GlobeNewswire)
May-28-25 04:05PM	Sana Biotechnology to Present at June 2025 Investor Conferences (GlobeNewswire) +12.50%
May-12-25 04:05PM	Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference (GlobeNewswire) +9.89% -10.25%
May-08-25 04:42PM	Sana: Q1 Earnings Snapshot (Associated Press Finance) +6.47%
04:05PM	Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
May-06-25 10:12PM	Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development (PR Newswire) -8.56%
Apr-29-25 08:00AM	Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics (PR Newswire)
Apr-24-25 06:00AM	Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare (PR Newswire)
Apr-22-25 05:45AM	Sana Biotechnology, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights - SANA (PR Newswire) +8.81%
Apr-21-25 12:56PM	Sana Biotechnology, Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights SANA (GlobeNewswire)
Apr-16-25 11:23AM	Is Sana Biotechnology Inc. (NASDAQ:SANA) the Best Biotech Penny Stock to Buy According to Hedge Funds? (Insider Monkey) -7.06%
Apr-10-25 12:39PM	Investors in Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights SANA (GlobeNewswire)
Apr-01-25 08:00AM	Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease (PR Newswire) -10.71%
Mar-25-25 08:00AM	Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica, an AI-Powered Drug Discovery Platform (Business Wire) -11.16%
Mar-24-25 11:45PM	Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421 (SeekingAlpha)
Mar-17-25 04:14PM	Sana: Q4 Earnings Snapshot (Associated Press Finance) -5.46% -17.69%
04:05PM	Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates (GlobeNewswire)
Mar-04-25 04:04PM	Is Sana Biotechnology (SANA) Among Jeff Bezos Investments in 2025? (Insider Monkey) +5.35%
Mar-01-25 06:02PM	Why Sana Biotechnology, Inc. (SANA) is Skyrocketing So Far in 2025 (Insider Monkey)
Feb-24-25 04:05PM	Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference (GlobeNewswire) -10.07%
Jan-28-25 10:42AM	Sana Biotechnology, Inc. (SANA): A Bull Case Theory (Insider Monkey)
Jan-22-25 07:59AM	Is Sana Biotechnology, Inc. (SANA) the Hottest Smid-Cap Stock So Far In 2025? (Insider Monkey) +19.86%
Jan-08-25 04:05PM	Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +160.61% -14.88%
10:34AM	Sana Biotechnology (SANA), eBay (EBAY) Are Among Todays Big Winners (Insider Monkey)
10:11AM	This Biotech Stock Soared 300% Overnight. Why It Can Go Higher. (Barrons.com)
07:26AM	Sana Biotechnology price target lowered to $7 from $8 at BofA (TipRanks)
07:25AM	This Biotech Stock Just Soared 240%. Why It Can Go Higher. (Barrons.com)
06:31AM	Tenvie raises $200M for brain drug R&D; Sana spikes on single patients results (BioPharma Dive)
Jan-07-25 04:05PM	Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression (GlobeNewswire) -5.71%
Dec-02-24 09:00AM	Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus (GlobeNewswire)
Nov-25-24 04:05PM	Sana Biotechnology to Present at December 2024 Investor Conferences (GlobeNewswire)
Nov-20-24 08:00AM	Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies (PR Newswire) +7.20%
06:30AM	Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer (PR Newswire)
Nov-13-24 09:55AM	Here's Why Sana (SANA) Could be Great Choice for a Bottom Fisher (Zacks) -6.34%
08:00AM	Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio (PR Newswire)
08:00AM	Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner (PR Newswire)
Nov-11-24 09:35AM	Down -24.69% in 4 Weeks, Here's Why Sana (SANA) Looks Ripe for a Turnaround (Zacks)
Nov-08-24 09:10AM	Sana: Q3 Earnings Snapshot (Associated Press Finance)
09:00AM	Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates (GlobeNewswire)
Nov-05-24 04:40AM	Sana to lay off staff, deepen autoimmune focus in latest retrenchment (BioPharma Dive) -9.84%
Nov-04-24 04:30PM	Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025 (GlobeNewswire)
Oct-23-24 08:00AM	Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence (PR Newswire)
Oct-16-24 08:58AM	Why Sana Biotechnology, Inc. (SANA) is the Penny Stock with the Biggest Upside Potential According to Analysts (Insider Monkey)
Oct-13-24 04:48PM	Sana Biotechnology, Inc. (SANA): Jeff Bezos Is Buying This Stock Now (Insider Monkey)
Oct-09-24 07:00AM	Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions (PR Newswire)
Oct-03-24 08:00AM	Invaio Sciences Appoints Andr Andonian as Chairman of the Board of Directors (PR Newswire)
Sep-30-24 04:05PM	Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference (GlobeNewswire)
Sep-26-24 06:00AM	Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry (PR Newswire) +13.56%
Aug-29-24 04:05PM	Sana Biotechnology to Present at September 2024 Investor Conferences (GlobeNewswire)
Aug-28-24 06:30AM	Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer (PR Newswire)
Aug-26-24 04:05PM	Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer (GlobeNewswire)
Aug-08-24 05:03PM	Sana: Q2 Earnings Snapshot (Associated Press Finance) +5.36%
04:05PM	Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates (GlobeNewswire)
Aug-06-24 06:30AM	Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner (PR Newswire)
Jul-29-24 07:00AM	GSK and Flagship Pioneering partner to discover novel medicines and vaccines (PR Newswire)
Jul-25-24 08:00AM	Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World (PR Newswire)
Jul-23-24 06:00AM	Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class (PR Newswire)
Jul-17-24 08:00AM	Alltrna Announces Updates to Its Board of Directors (PR Newswire) -7.00%
Jul-10-24 06:00AM	Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability (PR Newswire)
06:00AM	Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions (PR Newswire)
Jun-12-24 07:00AM	Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer (PR Newswire)
May-21-24 09:00AM	Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington's Disease and Other Glial-based Neurodegenerative Conditions (GlobeNewswire)

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wyrick Susan D.	See Remarks	Jan 02 '26	Option Exercise	0.00	7,500	0	188,290	Jan 06 04:18 PM
Wyrick Susan D.	See Remarks	Dec 13 '25	Option Exercise	0.00	3,400	0	181,663	Dec 16 04:16 PM
Wyrick Susan D.	See Remarks	Dec 03 '25	Option Exercise	0.00	10,000	0	180,828	Dec 05 05:04 PM
Wyrick Susan D.	See Remarks	Jun 03 '25	Option Exercise	0.00	10,000	0	170,395	Dec 05 05:04 PM
Wyrick Susan D.	See Remarks	Mar 07 '25	Option Exercise	0.00	3,250	0	158,231	Mar 10 08:13 PM
Cassidy Bernard J	EVP & General Counsel	Mar 07 '25	Option Exercise	0.00	11,041	0	115,823	Mar 10 08:12 PM
Harr Steve	President & CEO	Mar 07 '25	Option Exercise	0.00	50,000	0	7,889,750	Mar 10 08:12 PM
Wyrick Susan D.	See Remarks	Mar 02 '25	Option Exercise	0.00	1,525	0	155,471	Mar 03 07:28 PM
CHRISTIAN HORDO & KATHARINE HO	Officer	Feb 18 '25	Proposed Sale	3.16	75,000	237,000		Feb 18 04:27 PM

BOLD

Boundless Bio Inc

SANA

Sana Biotechnology Inc

Upgrade your FINVIZ experience